The first Aligos Therapeutics trade was made in Q3 2021.
Since then Jim Simons bought shares five more times and sold shares on seven occasions. The investor completely sold their stake between Q2 2024 and Q3 2024.
Avg closing price
Price range
Sold -30.8k shares
Q3 2024
Avg closing price
$12.44
Price range
$8.02
-
$19.43
Sold 4.9% shares (-1.58k shares)
Q2 2024
Avg closing price
$0.70
Price range
$0.35
-
$1.07
Increased shares by 65.0% (+12.7k shares)
Q1 2024
Avg closing price
$0.80
Price range
$0.64
-
$1.13
Increased shares by 52.5% (+6.74k shares)
Q4 2023
Avg closing price
$0.69
Price range
$0.56
-
$0.80
Sold 25.4% shares (-4.37k shares)
Q3 2023
Avg closing price
$0.89
Price range
$0.71
-
$1.06
Sold 4.9% shares (-891 shares)
Q2 2023
Avg closing price
$1.07
Price range
$0.89
-
$1.36
Sold 14.9% shares (-3.18k shares)
Q1 2023
Avg closing price
$1.53
Price range
$0.87
-
$2.11
Sold 27.1% shares (-7.93k shares)
Q4 2022
Avg closing price
$1.01
Price range
$0.89
-
$1.12
Sold 19.1% shares (-6.9k shares)
Q3 2022
Avg closing price
$1.33
Price range
$1.00
-
$1.60
Increased shares by 149.3% (+21.6k shares)
Q2 2022
Avg closing price
$1.36
Price range
$1.04
-
$2.14
Increased shares by 564.8% (+12.3k shares)
Q1 2022